title: Interferon alpha-2a monotherapy for necrobiotic xanthogranuloma.
authors.forename: S
authors.initials: S
authors.lastname: Georgiou
authors.forename: A
authors.initials: A
authors.lastname: Monastirli
authors.forename: N
authors.initials: N
authors.lastname: Kapranos
authors.forename: E
authors.initials: E
authors.lastname: Pasmatzi
authors.forename: T h
authors.initials: Th
authors.lastname: Sakkis
authors.forename: D
authors.initials: D
authors.lastname: Tsambaos
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001707:Biopsy, Needle; D005500:Follow-Up Studies; D006099:Granuloma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007279:Injections, Subcutaneous; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D011994:Recombinant Proteins; D012871:Skin Diseases / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D014973:Xanthomatosis / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins